Literature DB >> 10835515

Primary nodal gastrinomas.

M E Herrmann1, M C Ciesla, G Chejfec, S A DeJong, S L Yong.   

Abstract

BACKGROUND: The term primary lymph node gastrinoma was first used to describe a group of patients with gastrin-producing tumors present in lymph nodes located in a well-defined anatomic region. The patients had no known primary tumors in the pancreas or gastrointestinal tract and had disease-free survival for up to 18 years. The anatomic region in question has a triangular shape that extends from the cystic and common bile ducts to the second and third portion of the duodenum and the neck and body of the pancreas. The term gastrinoma triangle was coined to identify the area; in addition, it was postulated that lymph nodes located in the gastrinoma triangle normally contained neuroendocrine cells capable of secreting gastrin and other neuropeptides. From its inception, the postulate became the subject of controversy.
DESIGN: To extend previous observations, we examined the lymph nodes located in the gastrinoma triangle of 20 autopsy cases for the presence of neuroendocrine cells, as determined by immunohistochemistry, using antibodies to a panneuroendocrine substance (eg, synaptophysin) and a specific neuropeptide (eg, gastrin). Scanning for positive cells was performed by 2 observers (M.E.H. and M.C.C.). We compared the findings in these lymph nodes with lymph nodes obtained from axillary and inguinal dissections during surgical procedures.
RESULTS: In all, 417 lymph nodes were studied. Five of the 20 gastrinoma triangle cases contained synaptophysin reactive cells, whereas 3 had gastrin reactive cells. None of the axillary and inguinal lymph nodes contained neuroendocrine cells.
CONCLUSION: Our findings support the hypothesis of entrapment of neuroendocrine cells during development and the presence of primary nodal gastrinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835515     DOI: 10.5858/2000-124-0832-PNG

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  Primary lymph node gastrinoma: 2 cases and a review of the literature.

Authors:  Simon Harper; Richard W Carroll; Andrea Frilling; Susrutha K Wickremesekera; Simon Bann
Journal:  J Gastrointest Surg       Date:  2015-01-27       Impact factor: 3.452

Review 2.  Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.

Authors:  Jeffrey A Norton; Robert T Jensen
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

3.  Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.

Authors:  Tomotaka Akatsu; Kaori Kameyama; Yuki Nogami; Shigeyuki Kawachi; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

4.  Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

5.  Primary lymph node gastrinoma. A diagnosis of exclusion. A case for duodenotomy in the setting of a negative imaging for primary tumor: A case report and review of the literature.

Authors:  Annabelle Teng; Christopher Haas; David Y Lee; John Wang; Edward Lung; Fadi Attiyeh
Journal:  Int J Surg Case Rep       Date:  2014-10-17

6.  Zollinger-Ellison syndrome: Revelation of the gastrinoma triangle.

Authors:  Rong-Hsin Yang; Yum-Kung Chu
Journal:  Radiol Case Rep       Date:  2015-12-03

7.  Five-Year Long-Term Followup of a Primary Lymph node Gastrinoma: Is a Pancreaticoduodenectomy Justified?

Authors:  Bernd Jaenigen; Gian Kayser; Berthold Steinke; Oliver Thomusch
Journal:  Case Rep Med       Date:  2009-08-26

8.  Synchronous Peripancreatic Lymph Node Gastrinoma and Gastric Neuroendocrine Tumor Type 2.

Authors:  Hee Woo Lee; Jun-Won Chung; Yoon Jae Kim; Kwang Ahn Kwon; Eui Joo Kim; Keon Kuk Kim; Woon Ki Lee; Sun Jin Sym
Journal:  Clin Endosc       Date:  2016-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.